(SLE)
TEZATABEP MATRAXETAN(INNC)
THREE-ALPHA-HELIX BINDING PROTEIN, DERIVED FROM AN IMMUNOGLOBULIN G (IGG)-BINDING DOMAIN OF A STAPHYLOCOCCAL PROTEIN A (SPA), DESIGNED TO BIND RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2 (ERBB2, NEU, HER2), PRODUCED BY PEPTIDE SYNTHESIS, CONJUGATED AT THE C-TERMINAL CYS^61 TO ONE (3RS)- 2,5-DIOXO-1-(2-{2-[4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10- TETRAAZACYCLODODECAN-1-YL]ACETAMIDO}ETHYL)PYRROLIDIN-3-YL (MATRAXETAN) GROUP(WHO)
TEZATABEPUM MATRAXETANUM(INNM)